← Open Payments lookup

JOHN CHAPMAN: Open Payments

NPI 1184268617 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,501 in 153 payments from 17 companies in 2025. Trend: 2023 $3,602 · 2024 $3,798 · 2025 $3,501

Food & beverage: $3,501
CompanyPaymentsAmount
ViiV Healthcare Company66$1,685
Gilead Sciences, Inc.31$593
AstraZeneca Pharmaceuticals LP7$205
EMD Serono, Inc.8$195
Merck Sharp & Dohme LLC9$192
Novo Nordisk Inc10$168
Lilly USA, LLC4$82
Napo Pharmaceuticals Inc4$75
Antares Pharma, Inc.4$72
Madrigal Pharmaceuticals2$52

Products named: CABENUVA, APRETUDE, RUKOBIA, PIFELTRO, DOVATO, FARXIGA, Wegovy, MOUNJARO.

Industry payments across TX — which companies pay providers there.